U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C13H18O2.C6H14N2O2
Molecular Weight 352.4684
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEXIBUPROFEN LYSINE ANHYDROUS

SMILES

NCCCC[C@H](N)C(O)=O.CC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O

InChI

InChIKey=IHHXIUAEPKVVII-PTKYJSHISA-N
InChI=1S/C13H18O2.C6H14N2O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15;7-4-2-1-3-5(8)6(9)10/h4-7,9-10H,8H2,1-3H3,(H,14,15);5H,1-4,7-8H2,(H,9,10)/t10-;5-/m00/s1

HIDE SMILES / InChI

Molecular Formula C6H14N2O2
Molecular Weight 146.1876
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula C13H18O2
Molecular Weight 206.2808
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Dexibuprofen, S(+)-ibuprofen, is a non-steroidal anti-inflammatory drug and active dextrorotatory enantiomer of ibuprofen. Pharmacotherapeutic effects of dexibuprofen are more potent with lesser side effects than that of the racemic mixture of both isomers. In the acute and chronic treatment of osteoarthritis, it exhibits equivalent efficacy and tolerability as that of celecoxib. Dexibuprofen is a non-selective inhibitor of cyclooxygenase (COX), which is an enzyme involved in prostaglandin (mediators of pain and fever) and thromboxane (stimulators of blood clotting) synthesis via the arachidonic acid pathway. Dexibuprofen is a non-selective cyclooxygenase inhibitor and hence, it inhibits the activity of both COX-1 and COX-2. The inhibition of COX-2 activity decreases the synthesis of prostaglandins involved in mediating inflammation, pain, fever, and swelling while the inhibition of COX-1 is thought to cause some of the side effects of Dexibuprofen including GI ulceration. The major disadvantage of dexibuprofen is its low bioavailability, the account of its low solubility in physiological media.

Approval Year

Targets
PubMed

PubMed

TitleDatePubMed
Synthesis of (S)-ibuprofen via enantioselective degradation of racemic ibuprofen with an isolated yeast, Trichosporon cutaneum KPY 30802, in an interface bioreactor.
2001
Effectiveness evaluation of available without prescription medicines for postoperative pain treatment after "one day surgery".
2001 Jul-Sep
Bioequivalence study of two Ibuprofen formulations administered intravenously in healthy male volunteers.
2004
Solubility of (+/-)-ibuprofen and S (+)-ibuprofen in the presence of cosolvents and cyclodextrins.
2005
Enantioselective pharmacokinetics of ibuprofen and involved mechanisms.
2005
The effect of a dexibuprofen mouth rinse on experimental gingivitis in humans.
2005 Jun
An eutomer/distomer ratio near unity does not justify non-enantiospecific assay methods in bioequivalence studies.
2005 Oct
Similarity in structures of racemic and enantiomeric ibuprofen sodium dihydrates.
2005 Sep
Increased expression of cyclooxygenase and nitric oxide isoforms, and exaggerated sensitivity to prostaglandin E2, in the rat lumbar spinal cord 3 days after L5-L6 spinal nerve ligation.
2006 Feb
Beyond the white coat ceremony.
2006 Mar
(S)-Ibuprofen-imprinted polymers incorporating gamma-methacryloxypropyl-trimethoxysilane for CEC separation of ibuprofen enantiomers.
2006 Nov
Binding studies of taxanes to human serum albumin by bioaffinity chromatography and circular dichroism.
2006 Sep 11
A novel method for assessing inhibition of ibuprofen chiral inversion and its application in drug discovery.
2007 Apr 20
A review of ibuprofen and acetaminophen use in febrile children and the occurrence of asthma-related symptoms.
2007 Dec
Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.
2007 Feb
Effects of dexibuprofen on platelet function in humans: comparison with low-dose aspirin.
2007 Feb
Synthesis and biological activities of novel dexibuprofen tetraacetylriboflavin conjugates.
2007 Feb 1
[Pharmacokinetic interaction between phenitoin and dexibuprofen resulting in acute neurologic toxicity].
2007 Feb 17
Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs.
2007 Feb 23
An internet survey of 2,596 people with fibromyalgia.
2007 Mar 9
Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen.
2007 May
The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study.
2007 May 30
Effect of absorption rate on pharmacokinetics of ibuprofen in relation to chiral inversion in humans.
2007 Nov
NMR spectroscopic studies on the in vitro acyl glucuronide migration kinetics of Ibuprofen ((+/-)-(R,S)-2-(4-isobutylphenyl) propanoic acid), its metabolites, and analogues.
2007 Nov 15
Stereochemical identification of (R)- and (S)-ibuprofen using residual dipolar couplings, NMR, and modeling.
2007 Sep
Bioequivalence study of two formulations containing 400 mg dexibuprofen in healthy Indian subjects.
2008
Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
2008
Free drug metabolic clearance in elderly people.
2008
The role of peroxisome proliferator-activated receptors in the development and physiology of gametes and preimplantation embryos.
2008
S-ibuprofen effectively inhibits thromboxane B2 levels and platelet function in an experimental model of lipopolysaccharide-stimulated and non-stimulated whole blood.
2008
Emergency department patient knowledge concerning acetaminophen (paracetamol) in over-the-counter and prescription analgesics.
2008 Apr
Development of an affinity silica monolith containing human serum albumin for chiral separations.
2008 Apr 14
Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal.
2008 Apr 15
NMR evaluation of adipocyte fatty acid binding protein (aP2) with R- and S-ibuprofen.
2008 Apr 15
Spinal nerve ligation-induced activation of nuclear factor kappaB is facilitated by prostaglandins in the affected spinal cord and is a critical step in the development of mechanical allodynia.
2008 Aug 26
Formulation of a extended release tablet containing dexibuprofen.
2008 Dec
The effects and safety of dexibuprofen compared with ibuprofen in febrile children caused by upper respiratory tract infection.
2008 Dec
Population pharmacokinetic analysis of Ibuprofen enantiomers in preterm newborn infants.
2008 Dec
A randomized, crossover study to determine bioequivalence of two brands of dexibuprofen 400 mg tablets in healthy Asian adult male subjects of Indian origin.
2008 Jan
Analgesic synergy between topical opioids and topical non-steroidal anti-inflammatory drugs in the mouse model of thermal pain.
2008 Jan 28
Chiral separation of ibuprofen and chiral pharmacokinetics in healthy Chinese volunteers.
2008 Jan-Mar
Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers.
2008 Jul
Dexibuprofen (S(+)-isomer ibuprofen) reduces microglial activation and impairments of spatial working memory induced by chronic lipopolysaccharide infusion.
2008 May
Postoperative ketorolac does not predispose to pseudoarthrosis following posterior spinal fusion and instrumentation for adolescent idiopathic scoliosis.
2008 May 1
Impaired intrinsic chiral inversion activity of ibuprofen in rats with adjuvant-induced arthritis.
2008 Nov
Enantioselective formation of ibuprofen-S-acyl-glutathione in vitro in incubations of ibuprofen with rat hepatocytes.
2008 Sep
Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
2008 Sep 10
ADIDAC trial: analgesia with dexibuprofen versus ibuprofen in patients suffering from primary dysmenorrhea: a crossover trial.
2009
Influence of benzylamine on the resolution of ibuprofen with (+)-(R)-phenylethylamine via supercritical fluid extraction.
2009 Jun
Cyclic resolution of racemic ibuprofen via coupled efficient lipase and acid-base catalysis.
2009 Mar
Patents
Substance Class Chemical
Created
by admin
on Sat Dec 16 03:58:56 GMT 2023
Edited
by admin
on Sat Dec 16 03:58:56 GMT 2023
Record UNII
B5VWM9PYNC
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEXIBUPROFEN LYSINE ANHYDROUS
Common Name English
BENZENEACETIC ACID, .ALPHA.-METHYL-4-(2-METHYLPROPYL)-, (S)-, COMPD. WITH L-LYSINE (1:1)
Common Name English
(+)-(S)-P-ISOBUTYLHYDRATROPIC ACID, COMPOUND WITH L-LYSINE (1:1)
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID70150405
Created by admin on Sat Dec 16 03:58:57 GMT 2023 , Edited by admin on Sat Dec 16 03:58:57 GMT 2023
PRIMARY
CAS
113403-10-4
Created by admin on Sat Dec 16 03:58:57 GMT 2023 , Edited by admin on Sat Dec 16 03:58:57 GMT 2023
PRIMARY
FDA UNII
B5VWM9PYNC
Created by admin on Sat Dec 16 03:58:57 GMT 2023 , Edited by admin on Sat Dec 16 03:58:57 GMT 2023
PRIMARY
PUBCHEM
9819902
Created by admin on Sat Dec 16 03:58:57 GMT 2023 , Edited by admin on Sat Dec 16 03:58:57 GMT 2023
PRIMARY
SMS_ID
300000021795
Created by admin on Sat Dec 16 03:58:57 GMT 2023 , Edited by admin on Sat Dec 16 03:58:57 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
SOLVATE->ANHYDROUS
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY